Health Care·Biotechnology·$28.9B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.74 | N/A | +29.52% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.74 | N/A | +29.52% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Overall, management conveyed a sense of cautious optimism about the company's future. They emphasized their commitment to innovation despite current market challenges.
Management highlighted ongoing investments in R&D to drive future growth.
They acknowledged challenges in the current market but expressed confidence in long-term strategies.
Natera's earnings report shows a significant EPS loss, but the positive surprise indicates better-than-expected performance relative to some expectations. The stock's decline of 8.21% suggests that investors may have been looking for more positive signals or guidance. The lack of revenue data and forward guidance could contribute to uncertainty among investors moving forward.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
SUNCOR ENERGY INC NE
May 3, 2021